325 related articles for article (PubMed ID: 12435836)
21. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
22. Demographic, risk behaviour and personal network variables associated with prevalent hepatitis C, hepatitis B, and HIV infection in injection drug users in Winnipeg, Canada.
Wylie JL; Shah L; Jolly AM
BMC Public Health; 2006 Sep; 6():229. PubMed ID: 16970811
[TBL] [Abstract][Full Text] [Related]
23. Effectiveness of HIV/AIDS interventions on drug use and needle risk behaviors for out-of-treatment injection drug users.
Booth RE; Kwiatkowski CF; Stephens RC
J Psychoactive Drugs; 1998; 30(3):269-78. PubMed ID: 9798793
[TBL] [Abstract][Full Text] [Related]
24. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
25. A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups.
Lelutiu-Weinberger C; Pouget ER; Des Jarlais DD; Cooper HL; Scheinmann R; Stern R; Strauss SM; Hagan H
Soc Sci Med; 2009 Feb; 68(3):579-90. PubMed ID: 19062148
[TBL] [Abstract][Full Text] [Related]
26. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
Wodak A; Crofts N
Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
[No Abstract] [Full Text] [Related]
27. Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Ward J; Topp L; Iversen J; Wand H; Akre S; Kaldor J; Maher L
Aust N Z J Public Health; 2011 Oct; 35(5):421-6. PubMed ID: 21973248
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of hepatitis B and C among HIV positive patients in Georgia and its associated risk factors.
Badridze N; Chkhartishvili N; Abutidze A; Gatserelia L; Sharvadze L
Georgian Med News; 2008 Dec; (165):54-60. PubMed ID: 19124918
[TBL] [Abstract][Full Text] [Related]
29. Illicit drug injectors' strategies for cleaning needles and syringes: findings from qualitative research.
Hughes R
Scand J Public Health; 2000 Jun; 28(2):158-60. PubMed ID: 10954144
[No Abstract] [Full Text] [Related]
30. Blood-borne and sexual transmission of human herpesvirus 8 in women with or at risk for human immunodeficiency virus infection.
Cannon MJ; Dollard SC; Smith DK; Klein RS; Schuman P; Rich JD; Vlahov D; Pellett PE;
N Engl J Med; 2001 Mar; 344(9):637-43. PubMed ID: 11228278
[TBL] [Abstract][Full Text] [Related]
31. Erratum to: The prevalence of HIV, HBV, HCV, and HIV-related risk-taking behaviors among Palestinian injecting drug users in the East Jerusalem Governorate.
Stulhofer A; Chetty A; Rabie RA; Jwehan I; Ramlawi A
J Urban Health; 2012 Aug; 89(4):677. PubMed ID: 22782840
[TBL] [Abstract][Full Text] [Related]
32. The prevalence of HIV, HBV, HCV, and HIV-related risk-taking behaviors among Palestinian injecting drug users in the East Jerusalem Governorate.
Stulhofer A; Chetty A; Rabie RA; Jwehan I; Ramlawi A
J Urban Health; 2012 Aug; 89(4):671-6. PubMed ID: 22674463
[TBL] [Abstract][Full Text] [Related]
33. A syringe exchange programme in prison as prevention strategy against HIV infection and hepatitis B and C in Berlin, Germany.
Stark K; Herrmann U; Ehrhardt S; Bienzle U
Epidemiol Infect; 2006 Aug; 134(4):814-9. PubMed ID: 16371183
[TBL] [Abstract][Full Text] [Related]
34. Socio-behavioral and geographic correlates of prevalent hepatitis C virus infection among young injection drug users in metropolitan Baltimore and Chicago.
Boodram B; Golub ET; Ouellet LJ
Drug Alcohol Depend; 2010 Sep; 111(1-2):136-45. PubMed ID: 20472373
[TBL] [Abstract][Full Text] [Related]
35. Seroprevalence of HBV, HCV and HIV infection among intravenous drug users in Shahr-e-Kord, Islamic Republic of Iran.
Imani R; Karimi A; Rouzbahani R; Rouzbahani A
East Mediterr Health J; 2008; 14(5):1136-41. PubMed ID: 19161086
[TBL] [Abstract][Full Text] [Related]
36. HIV infection and AIDS among drug injectors at Rio de Janeiro: perspectives and unanswered questions.
Lima ES; Bastos FI; Telles PR; Friedman SR
Bull Narc; 1993; 45(1):107-15. PubMed ID: 8305901
[TBL] [Abstract][Full Text] [Related]
37. Distributive syringe sharing among young adult injection drug users in five U.S. cities.
Golub ET; Strathdee SA; Bailey SL; Hagan H; Latka MH; Hudson SM; Garfein RS;
Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S30-8. PubMed ID: 17398039
[TBL] [Abstract][Full Text] [Related]
38. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
39. [The efficacy of needle exchange programs in the prevention of HIV and hepatitis infection among injecting drug users].
Takács IG; Demetrovics Z
Psychiatr Hung; 2009; 24(4):264-81. PubMed ID: 19949245
[TBL] [Abstract][Full Text] [Related]
40. Cost-effectiveness of harm reduction in preventing hepatitis C among injection drug users.
Pollack HA
Med Decis Making; 2001; 21(5):357-67. PubMed ID: 11575485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
